436 related articles for article (PubMed ID: 24764241)
1. In vitro platforms for evaluating liver toxicity.
Bale SS; Vernetti L; Senutovitch N; Jindal R; Hegde M; Gough A; McCarty WJ; Bakan A; Bhushan A; Shun TY; Golberg I; DeBiasio R; Usta BO; Taylor DL; Yarmush ML
Exp Biol Med (Maywood); 2014 Sep; 239(9):1180-1191. PubMed ID: 24764241
[TBL] [Abstract][Full Text] [Related]
2. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions.
Bale SS; Borenstein JT
Drug Metab Dispos; 2018 Nov; 46(11):1638-1646. PubMed ID: 30115643
[TBL] [Abstract][Full Text] [Related]
4. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
Chang R; Emami K; Wu H; Sun W
Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
[TBL] [Abstract][Full Text] [Related]
5. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
6. The use of hepatocytes to investigate drug toxicity.
Gómez-Lechón MJ; Castell JV; Donato MT
Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064
[TBL] [Abstract][Full Text] [Related]
7. A human liver microphysiology platform for investigating physiology, drug safety, and disease models.
Vernetti LA; Senutovitch N; Boltz R; DeBiasio R; Shun TY; Gough A; Taylor DL
Exp Biol Med (Maywood); 2016 Jan; 241(1):101-14. PubMed ID: 26202373
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic human physiomimetic liver model as a screening platform for drug induced liver injury.
Dey S; Bhat A; Janani G; Shandilya V; Gupta R; Mandal BB
Biomaterials; 2024 Oct; 310():122627. PubMed ID: 38823194
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
[TBL] [Abstract][Full Text] [Related]
10. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
[TBL] [Abstract][Full Text] [Related]
11. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury.
Xiao RR; Lv T; Tu X; Li P; Wang T; Dong H; Tu P; Ai X
Biotechnol Bioeng; 2021 Dec; 118(12):4687-4698. PubMed ID: 34478150
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
13. Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.
Bale SS; Moore L; Yarmush M; Jindal R
Tissue Eng Part B Rev; 2016 Oct; 22(5):383-394. PubMed ID: 27049038
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic organ-on-a-chip models of human liver tissue.
Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
[TBL] [Abstract][Full Text] [Related]
15. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.
Cosgrove BD; King BM; Hasan MA; Alexopoulos LG; Farazi PA; Hendriks BS; Griffith LG; Sorger PK; Tidor B; Xu JJ; Lauffenburger DA
Toxicol Appl Pharmacol; 2009 Jun; 237(3):317-30. PubMed ID: 19362101
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device.
Yeon JH; Na D; Park JK
Electrophoresis; 2010 Sep; 31(18):3167-74. PubMed ID: 20872616
[TBL] [Abstract][Full Text] [Related]
17. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
18. Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?
Kia R; Sison RL; Heslop J; Kitteringham NR; Hanley N; Mills JS; Park BK; Goldring CE
Br J Clin Pharmacol; 2013 Apr; 75(4):885-96. PubMed ID: 22703588
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of potential hepatotoxicity induced by drugs.
Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
Andersson TB
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):234-238. PubMed ID: 28470941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
